CVS Health Corporation
NYSECVS Health has given back a little ground this week, but the narrative from the Street continues to move in one direction: higher. The stock dipped 1.9% on Tuesday to close at $94.18, trimming its weekly gain to -1.0%. That modest pullback follows a remarkable 21.8% run over the past month — the bulk of it driven by the May 6 earnings beat, which sent shares up more than 8% in a…
Snapshot as of 22 Jun 2026
CVS Health has given back a little ground this week, but the narrative from the Street continues to move in one direction: higher. The stock dipped 1.9% on Tuesday to close at $94.18, trimming its weekly gain to -1.0%.…
CVS Health has just delivered its biggest weekly gain in years — up 18% — and the analyst community has responded with a rare, almost unanimous round of target-price upgrades. The week's most compelling story is not…
CVS Health enters its May 14 earnings report carried by a wave of analyst upgrades that has reset expectations sharply higher heading into the print. The most striking pre-earnings signal is from the Street, where at…
CVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story…
CVS Health reports Q1 2026 results on May 6 as a stock that has quietly re-rated higher — and with the short sellers who drove much of the bearish narrative now stepping back. Short interest has fallen sharply over the…
CVS Health enters its May 6 earnings call in a notably better place than it left the last few months — up 15.5% over the past month and shedding short positions at pace, yet options traders are quietly loading up on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVS — free to start on ORTEX.
Sign up for free →Open CVS on ORTEX